Vulnerability Monitor

The vendors, products, and vulnerabilities you care about

CVE-2022-30277

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

Published

2022-06-02T14:15:51.850

Last Modified

2024-11-21T07:02:29.147

Status

Modified

Source

[email protected]

Severity

CVSSv3.1: 5.7 (MEDIUM)

CVSSv2 Vector

AV:L/AC:L/Au:N/C:P/I:P/A:N

  • Access Vector: LOCAL
  • Access Complexity: LOW
  • Authentication: NONE
  • Confidentiality Impact: PARTIAL
  • Integrity Impact: PARTIAL
  • Availability Impact: NONE
Exploitability Score

3.9

Impact Score

4.9

Weaknesses
  • Type: Secondary
    CWE-613
  • Type: Primary
    CWE-613
Affected Vendors & Products
Type Vendor Product Version/Range Vulnerable?
Application bd synapsys 4.20 Yes
Application bd synapsys 4.20 Yes
Application bd synapsys 4.30 Yes
References